XML 92 R81.htm IDEA: XBRL DOCUMENT v3.24.3
POLICY LIABILITIES - Reconciliation of Future Policy Benefits (Details) - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits $ 79,672 $ 83,718
Deferred reinsurance gain liability 165 175
Liability for Future Policy Benefits Reconciling Items    
Liability for Future Policy Benefit, Activity [Line Items]    
Deferred profit liability 2,000 1,806
Deferred reinsurance gain liability 949 1,012
Intercompany eliminations    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits [1] (4,711) (5,017)
Corporate and other | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 3,897 4,225
Cancer | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 30,502 32,652
Cancer | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 30,502 32,652
Medical and other health | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 10,103 10,560
Medical and other health | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 10,103 10,560
Life insurance | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 21,829 23,243
Life insurance | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 21,829 23,243
Life insurance | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 985 911
Life insurance | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 985 911
Accident | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 659 621
Accident | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 659 621
Disability | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 732 770
Disability | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 732 770
Critical Care | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 7,257 7,216
Critical Care | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 7,257 7,216
Hospital Indemnity | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 821 836
Hospital Indemnity | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 821 836
Dental/Vision | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 260 272
Dental/Vision | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 260 272
Other | Aflac Japan    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 3,875 4,090
Other | Aflac Japan | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 3,875 4,090
Other | Aflac U.S.    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits 514 521
Other | Aflac U.S. | Operating Segments    
Liability for Future Policy Benefit, Activity [Line Items]    
Future policy benefits $ 514 $ 521
[1] Elimination entry necessary due to the internal reinsurance transactions with Aflac Re and to recapture a portion of policy liabilities ceded externally as a result of the reinsurance retrocession transaction. See Note 8 of the Notes to the Consolidated Financial Statements in the 2023 Annual Report.